Alliancebernstein L.P. Fulcrum Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 74,590 shares of FULC stock, worth $658,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,590

Previous 65,590 13.72%

Holding current value

$658,629

Previous $188,000 172.87%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.51 - $7.38 $22,589 - $66,420	9,000 Added 13.72%	74,590 $513,000
Q3 2024 Nov 14, 2024	SELL	$3.18 - $9.74 $500,506 - $1.53 Million	-157,392 Reduced 70.59%	65,590 $234,000
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $215,381 - $335,318	36,017 Added 19.26%	222,982 $1.38 Million
Q1 2024 May 14, 2024	SELL	$6.7 - $12.0 $351,703 - $629,916	-52,493 Reduced 21.92%	186,965 $1.76 Million
Q4 2023 Feb 14, 2024	BUY	$3.18 - $6.86 $18,825 - $40,611	5,920 Added 2.53%	239,458 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$3.25 - $6.08 $758,998 - $1.42 Million	233,538 New	233,538 $1.04 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $37,073 - $183,269	13,100 Added 30.61%	55,900 $159,000
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $26,052 - $43,420	5,200 Added 13.83%	42,800 $311,000
Q3 2022 Nov 15, 2022	BUY	$4.92 - $9.1 $20,172 - $37,310	4,100 Added 12.24%	37,600 $304,000
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $49,980 - $285,600	11,900 Added 55.09%	33,500 $164,000
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $70,000 - $142,200	5,000 Added 30.12%	21,600 $382,000
Q2 2021 Jul 30, 2021	BUY	$8.09 - $12.0 $7,281 - $10,800	900 Added 5.73%	16,600 $174,000
Q3 2020 Nov 12, 2020	BUY	$7.22 - $20.7 $5,054 - $14,490	700 Added 4.67%	15,700 $125,000
Q2 2020 Aug 13, 2020	BUY	$9.11 - $22.06 $136,650 - $330,900	15,000 New	15,000 $274,000
Q4 2019 Feb 18, 2020	SELL	$4.46 - $18.14 $2.27 Million - $9.24 Million	-509,369 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.64 - $14.89 $3.38 Million - $7.58 Million	509,369 New	509,369 $3.38 Million

Others Institutions Holding FULC

# of Institutions

133

Shares Held

55.6M

Call Options Held

886K

Put Options Held

93.3K

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $460M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Fulcrum Therapeutics, Inc. Transaction History